201 related articles for article (PubMed ID: 28751734)
1. Glucocorticoid therapy regulates podocyte motility by inhibition of Rac1.
McCaffrey JC; Webb NJ; Poolman TM; Fresquet M; Moxey C; Zeef LAH; Donaldson IJ; Ray DW; Lennon R
Sci Rep; 2017 Jul; 7(1):6725. PubMed ID: 28751734
[TBL] [Abstract][Full Text] [Related]
2. Levamisole in steroid-sensitive nephrotic syndrome: usefulness in adult patients and laboratory insights into mechanisms of action via direct action on the kidney podocyte.
Jiang L; Dasgupta I; Hurcombe JA; Colyer HF; Mathieson PW; Welsh GI
Clin Sci (Lond); 2015 Jun; 128(12):883-93. PubMed ID: 25626449
[TBL] [Abstract][Full Text] [Related]
3. Dose- and time-dependent glucocorticoid receptor signaling in podocytes.
Guess A; Agrawal S; Wei CC; Ransom RF; Benndorf R; Smoyer WE
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F845-53. PubMed ID: 20630936
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins.
Wada T; Pippin JW; Marshall CB; Griffin SV; Shankland SJ
J Am Soc Nephrol; 2005 Sep; 16(9):2615-25. PubMed ID: 15987750
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid receptor wields chromatin interactions to tune transcription for cytoskeleton stabilization in podocytes.
Wang H; Duan A; Zhang J; Wang Q; Xing Y; Qin Z; Liu Z; Yang J
Commun Biol; 2021 Jun; 4(1):675. PubMed ID: 34083716
[TBL] [Abstract][Full Text] [Related]
6. Dosage-dependent role of Rac1 in podocyte injury.
Wan X; Lee MS; Zhou W
Am J Physiol Renal Physiol; 2016 Apr; 310(8):F777-F784. PubMed ID: 26792065
[TBL] [Abstract][Full Text] [Related]
7. Loss of the podocyte glucocorticoid receptor exacerbates proteinuria after injury.
Zhou H; Tian X; Tufro A; Moeckel G; Ishibe S; Goodwin J
Sci Rep; 2017 Aug; 7(1):9833. PubMed ID: 28852159
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of microRNA-30a prevents puromycin aminonucleoside-induced podocytic apoptosis by upregulating the glucocorticoid receptor α.
Xie H; Lin HL; Wang N; Sun YL; Kan Y; Guo H; Chen JL; Fang M
Mol Med Rep; 2015 Oct; 12(4):6043-52. PubMed ID: 26299668
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization.
Ransom RF; Lam NG; Hallett MA; Atkinson SJ; Smoyer WE
Kidney Int; 2005 Dec; 68(6):2473-83. PubMed ID: 16316324
[TBL] [Abstract][Full Text] [Related]
10. Disease-causing mutations of RhoGDIα induce Rac1 hyperactivation in podocytes.
Auguste D; Maier M; Baldwin C; Aoudjit L; Robins R; Gupta IR; Takano T
Small GTPases; 2016 Apr; 7(2):107-21. PubMed ID: 26726844
[TBL] [Abstract][Full Text] [Related]
11. A novel splicing variant of small nucleolar RNA host gene 4 is a podocyte-selective non-coding RNA upregulated in response to puromycin aminonucleoside-induced podocyte injury.
Horikawa A; Yoneda T; Yaoita E; Yamaguchi K; Shigenobu S; Kuramochi M; Yamate J; Inui T; Ishibashi O
J Biochem; 2019 May; 165(5):447-454. PubMed ID: 30597036
[TBL] [Abstract][Full Text] [Related]
12. The impact of steroids on the injured podocytes in nephrotic syndrome.
Hosseiniyan Khatibi SM; Ardalan M; Abediazar S; Zununi Vahed S
J Steroid Biochem Mol Biol; 2020 Feb; 196():105490. PubMed ID: 31586640
[TBL] [Abstract][Full Text] [Related]
13. α Actinin 4 (ACTN4) Regulates Glucocorticoid Receptor-mediated Transactivation and Transrepression in Podocytes.
Zhao X; Khurana S; Charkraborty S; Tian Y; Sedor JR; Bruggman LA; Kao HY
J Biol Chem; 2017 Feb; 292(5):1637-1647. PubMed ID: 27998979
[TBL] [Abstract][Full Text] [Related]
14. Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases.
Dong N; Meng L; Xue R; Yu M; Zhao Z; Liu X
Int Urol Nephrol; 2017 Aug; 49(8):1489-1506. PubMed ID: 28528353
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids.
Wu J; Zheng C; Fan Y; Zeng C; Chen Z; Qin W; Zhang C; Zhang W; Wang X; Zhu X; Zhang M; Zen K; Liu Z
J Am Soc Nephrol; 2014 Jan; 25(1):92-104. PubMed ID: 24029422
[TBL] [Abstract][Full Text] [Related]
16. Kindlin-2 Association with Rho GDP-Dissociation Inhibitor
Sun Y; Guo C; Ma P; Lai Y; Yang F; Cai J; Cheng Z; Zhang K; Liu Z; Tian Y; Sheng Y; Tian R; Deng Y; Xiao G; Wu C
J Am Soc Nephrol; 2017 Dec; 28(12):3545-3562. PubMed ID: 28775002
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-4 ectodomain evokes mobilization of podocyte TRPC6 channels and their associated pathways: An essential role for integrin signaling.
Kim EY; Roshanravan H; Dryer SE
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2610-20. PubMed ID: 26193076
[TBL] [Abstract][Full Text] [Related]
18. PLCE1 regulates the migration, proliferation, and differentiation of podocytes.
Yu S; Choi WI; Choi YJ; Kim HY; Hildebrandt F; Gee HY
Exp Mol Med; 2020 Apr; 52(4):594-603. PubMed ID: 32238860
[TBL] [Abstract][Full Text] [Related]
19. Trehalose, an mTOR independent autophagy inducer, alleviates human podocyte injury after puromycin aminonucleoside treatment.
Kang YL; Saleem MA; Chan KW; Yung BY; Law HK
PLoS One; 2014; 9(11):e113520. PubMed ID: 25412249
[TBL] [Abstract][Full Text] [Related]
20. The Role of Glucocorticoid Receptors in Podocytes and Nephrotic Syndrome.
Zhao X; Hwang DY; Kao HY
Nucl Receptor Res; 2018; 5():. PubMed ID: 30417008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
